The Neonatal Galactose ELISA is designed for the quantitative determination of galactose in neonatal blood spots. It is for in vitro diagnostic use as an aid in screening newborns for elevated galactose levels as seen in galactosemia.
FDA cleared for In Vitro Diagnostic (IVD) use in the United States. CE Marked for IVD use outside the United States.
|Analyte / Target||Galactose|
|Base Catalog Number||553300|
|Diagnostic Solutions||Newborn Screening|
|Sample Type||Dried Blood Spot|
|Sample Volume||2 x 3.2 mm (1/8”) or 4.7 mm (3/16”) dried blood spot|5 uL Whole Blood|
|Usage Statement||FDA cleared for In Vitro Diagnostic (IVD) use in the United States. CE Marked for IVD use outside the United States.|